Abbott Laboratories (ABT) Enterprise Value (EV): $171 Billion

Since December 31st, 2007, Abbott Laboratories's enterprise value (ev) has increased from $41.9 Billion to $171 Billion at June 5th, 2020.

From 2007 to 2020 Abbott Laboratories's highest enterprise value (ev) was $183 Billion
Abbott Laboratories's lowest enterprise value (ev) during that period was $30.9 Billion
Abbott Laboratories's average enterprise value (ev) from 2007 to 2020 Abbott Laboratories's was $71.3 Billion

Abbott Laboratories's enterprise value (ev) as of June 5th, 2020 of $171 Billion was higher than its peers in the Medical Appliances & Equipment industry group of May 31st, 2020 of 5.43 Billion. From December 31st, 2007 to June 5th, 2020, Abbott Laboratories's average enterprise value (ev) was 71.3 Billion compared to an industry average of 371 Billion.

About Abbott Laboratories

Abbott Laboratories engages in the discovery, development, manufacture and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, and Vascular Products. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure and other medical device products. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.